Compare WHWK & RAAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WHWK | RAAQ |
|---|---|---|
| Founded | 2007 | 2024 |
| Country | United States | United States |
| Employees | 23 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.4M | 269.6M |
| IPO Year | N/A | N/A |
| Metric | WHWK | RAAQ |
|---|---|---|
| Price | $4.16 | $13.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 531.1K | ★ 798.1K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $9.62 |
| 52 Week High | $5.50 | $13.50 |
| Indicator | WHWK | RAAQ |
|---|---|---|
| Relative Strength Index (RSI) | 46.88 | 80.33 |
| Support Level | $3.85 | $10.32 |
| Resistance Level | $4.38 | N/A |
| Average True Range (ATR) | 0.35 | 0.40 |
| MACD | -0.00 | 0.19 |
| Stochastic Oscillator | 20.27 | 97.45 |
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
Real Asset Acquisition Corp is a blank check company.